Nano Magic Valuation

Is NMGX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NMGX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate NMGX's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate NMGX's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NMGX?

Key metric: As NMGX is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for NMGX. This is calculated by dividing NMGX's market cap by their current revenue.
What is NMGX's PS Ratio?
PS Ratio	3.1x
Sales	US$2.57m
Market Cap	US$7.92m

NMGX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.5x
Enterprise Value/EBITDA	-3.1x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does NMGX's PS Ratio compare to its peers?

The above table shows the PS ratio for NMGX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.7x
BON Bon Natural Life	0.2x	n/a	US$5.4m
DNMR Danimer Scientific	0.5x	47.8%	US$18.5m
NNUP Nocopi Technologies	10x	n/a	US$18.4m
ABLT American Biltrite	0.02x	n/a	US$2.9m
NMGX Nano Magic	3.1x	n/a	US$7.9m

Price-To-Sales vs Peers: NMGX is expensive based on its Price-To-Sales Ratio (3.1x) compared to the peer average (2.7x).

Price to Sales Ratio vs Industry

How does NMGX's PS Ratio compare vs other companies in the US Chemicals Industry?

10 Companies	Price / Sales	Estimated Growth	Market Cap
TSE Trinseo	0.03x	5.0%	US$117.53m
ALTO Alto Ingredients	0.1x	3.1%	US$106.54m
BON Bon Natural Life	0.2x	n/a	US$5.36m
ABLT American Biltrite	0.02x	n/a	US$2.91m

10 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: NMGX is expensive based on its Price-To-Sales Ratio (3.1x) compared to the US Chemicals industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is NMGX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NMGX PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	3.1x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate NMGX's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Trinseo

US$117.5m

Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.

TSE

US$3.32

-8.3%

-48.8%

CMOC Group

HK$167.3b

Engages in the mining, beneficiation, smelting, and refining of base and rare metals.

CMCL.F

HK$0.76

37.8%

Chemtrade Logistics Income Fund

CA$1.4b

Offers industrial chemicals and services in Canada, the United States, and South America.

CGIF.F

CA$8.30

5.2%

31.5%